Life technologies corporation:1107072 [22-001713]
Ended Awarded
- Contract number
- 75N92B22F00001
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7 Part of Thermo Electron Corporation
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,000
Award facts
- Contract value 100% obligated
- $16,000.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Carlsbad, CA 92008, USA
Award details come from SAM.gov/FPDS.
About this award
Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a contract valued at $16,000.04 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) on March 2, 2022, with an ultimate completion date of March 17, 2023. This Blanket Purchase Agreement (BPA) call was awarded on a firm fixed-price basis without set-aside designation, reflecting the contractor's competitive positioning in federal scientific procurement. The work is to be performed at the company's facility in Carlsbad, California. Life Technologies Corporation is a prominent manufacturer of scientific instruments, reagents, and consumables that supplies cutting-edge biotechnology products and services to federal agencies, including genetic analyzers, real-time PCR systems, flow cytometers, and nucleic acid extraction equipment.
As a subsidiary of Thermo Electron Corporation, Life Technologies has established itself as a key supplier to the National Institutes of Health and other federal agencies supporting critical research initiatives. The relatively modest contract value suggests this represents a task order or limited-scope purchase under an existing BPA vehicle, likely for laboratory reagents, consumables, or maintenance services related to genetic analysis or immunodiagnostic equipment. The NIAMSD funding supports the agency's mission in conducting and supporting research on arthritis, musculoskeletal diseases, and skin conditions, areas where Life Technologies' molecular and genetic analysis capabilities align with the institute's research requirements.
Quick answers
Who was awarded contract 75N92B22F00001?
75N92B22F00001 was awarded to Life Technologies Corporation by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on March 2, 2022.
How much is contract 75N92B22F00001 worth?
The government has obligated $16,000 on 75N92B22F00001.
Is contract 75N92B22F00001 an order under another contract?
Yes. 75N92B22F00001 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N92B22F00001 competed?
The extent of competition for 75N92B22F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award